Evangeline Lilly revealed she has brain damage and decreased brain function after suffering a concussion from a fall, and is now working with doctors to address the injury.
Kim Kardashian underwent a brain scan on 'The Kardashians' that showed low activity in her frontal lobes, which she took as an explanation for her stress, though medical experts question the reliability of such scans and their interpretation, highlighting the influence of celebrity culture on health narratives.
Researchers have developed DunedinPACNI, a tool that uses a single brain scan taken midlife to accurately assess biological aging and predict risks of diseases like dementia, potentially enabling earlier interventions to improve health outcomes.
Researchers have developed a new MRI-based tool called DunedinPACNI that can measure how fast a person is aging and predict their risk of developing dementia and other age-related diseases decades in advance, using just a single brain scan. This innovative approach could enable early interventions and improve health outcomes by identifying at-risk individuals before symptoms appear.
A new study suggests that Alzheimer's disease may begin up to 20 years before memory loss symptoms appear, with early signs including spatial awareness issues, highlighting the importance of early detection for better intervention and potential prevention.
A 10-minute brain scan could potentially detect dementia up to nine years before symptoms appear, with 80% accuracy, according to a study using fMRI scans and AI algorithms. This early detection method, if confirmed in larger studies, could become routine in memory clinics and aid in the development of preventive treatments. However, the NHS currently lacks the capacity for widespread implementation, necessitating further investment.
The AHEAD study aims to identify risk factors for Alzheimer's, such as the buildup of amyloid proteins, in healthy individuals 15-20 years before symptom onset, offering them the opportunity to participate in a new FDA-approved medication trial designed to prevent or lessen the effects of the disease. The study, conducted at 75 sites nationwide, is open to all populations and aims to provide free monitoring and access to care, particularly for minority groups who may face disparities in healthcare access.